Addex Therapeutics Aktie

0,0405 EUR +0,0015 EUR +3,85 %

14:18:39

STU

0,0390 CHF +0,0030 CHF +8,33 %

13:36:23

BRX

Addex Therapeutics jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)

Jetzt loslegen

Direkt handeln

Marktkap.6,26 Mio. EUR

KGV0,80Div. Rendite0,00%

WKNA0MSH6

ISINCH0029850754

SymbolADDXF

Addex Therapeutics Aktien News

Sortieren:Datum Meistgelesen

06.06.25GlobeNewswireAddex GABAB PAM Candidate Demonstrates Robust Anti-Tussive Activity in Multiple Chronic Cough Preclinical Models

05.06.25GlobeNewswireAddex to Present Positive GABAB PAM Chronic Cough Data at the 10th American Cough Conference

03.06.25GlobeNewswireAddex Convenes Annual General Meeting 2025

WerbungAddex Therapeutics-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero

12.05.25GlobeNewswireAddex Partner Indivior Advances GABAB Positive Allosteric Modulator Program Successfully Through IND Enabling Studies

30.04.25GlobeNewswireAddex Enters Option Agreement with Sinntaxis for an Exclusive License to Intellectual Property Covering the Use of mGlu5 Inhibitors in Brain Injury Recovery

25.04.25GlobeNewswireAddex Reports Full Year 2024 Financial Results and Provides Corporate Update

24.04.25GlobeNewswireAddex Therapeutics to Release Full-Year 2024 Financial Results and Host Conference Call on April 25, 2025

17.04.25GlobeNewswireAddex Regains Rights to Phase 2 mGlu2 PAM Asset ADX71149

08.01.25GlobeNewswireAddex to Present at the 2025 Swiss Equities Baader Conference

22.11.24GlobeNewswireAddex Reports Third Quarter 2024 Financial Results and Provides Corporate Update

11.11.24GlobeNewswireAddex Provisional 2024 Third Quarter Results Showed Net Loss Compared to Second Quarter 2024

30.09.24GlobeNewswireAddex Therapeutics Reports 2024 Half Year and Second Quarter Financial Results and Provides Corporate Update

19.09.24GlobeNewswireAddex Provisional 2024 Half-Year and Second Quarter Result increased from a Net loss to a Net Profit

04.09.24GlobeNewswireAddex to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

27.08.24GlobeNewswireAddex and Indivior Select Clinical Candidates from GABAB Positive Allosteric Modulator Research Collaboration

22.07.24GlobeNewswireAddex’s Partner Discontinues ADX71149 development in Epilepsy

15.07.24GlobeNewswireAddex Presents Positive Results from GABAB PAM Cough Program at the Thirteenth London International Cough Symposium (13th LICS)

12.07.24GlobeNewswireAddex To Present at the Thirteenth London International Cough Symposium (13th LICS)

01.07.24GlobeNewswireAddex Shareholders Approve All Resolutions at Annual General Meeting

06.06.24GlobeNewswireAddex Therapeutics Reports Q1 2024 Financial Results and Provides Corporate Update

05.06.24GlobeNewswireAddex Convenes Annual General Meeting 2024

31.05.24GlobeNewswireAddex Therapeutics to Release Q1 2024 Financial Results and Host Conference Call on June 6, 2024

08.05.24GlobeNewswireAddex to Present at Bio€quity Europe 2024

29.04.24GlobeNewswireAddex Provides Update on ADX71149 Phase 2 Epilepsy Study

19.04.24GlobeNewswireAddex to Present at the Swiss Biotech Day 2024

18.04.24GlobeNewswireAddex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update

11.04.24GlobeNewswireAddex Therapeutics to Release Full-Year 2023 Financial Results and Host Conference Call on April 18, 2024

03.04.24GlobeNewswireAddex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Modulator Therapeutics for Neurological Disorders

14.03.24GlobeNewswireAddex to Present at the Bio-Europe Spring 2024 Conference

31.01.24GlobeNewswireAddex Enters into At-The-Market ADS Offering Agreement with H.C. Wainwright & Co. LLC.

09.01.24GlobeNewswireAddex to Present at the Swiss Equities Baader Conference

05.01.24GlobeNewswireAddex to Present at Biotech Showcase™ 2024

20.12.23GlobeNewswireAddex Shareholders Approve All Resolutions at Extraordinary General Meeting

14.12.23GlobeNewswireAddex Creates Treasury Shares

29.11.23GlobeNewswireAddex Reports Q3 2023 Financial Results and Provides Corporate Update

28.11.23GlobeNewswireAddex Convenes Extraordinary General Meeting

23.11.23GlobeNewswireAddex Therapeutics to Release Third Quarter 2023 Financial Results and Host Conference Call on November 29, 2023

14.11.23GlobeNewswireAddex ADX71149 Epilepsy Phase 2 Study Completes Recruitment of Patients

08.11.23GlobeNewswireAddex Regains Nasdaq Listing Compliance

02.11.23GlobeNewswireAddex Announces Participation in the Bio-Europe 2023 Conference

Addex Therapeutics News

Addex Therapeutics News: auf dieser Seite finden Sie alle Addex Therapeutics News und Nachrichten zur Addex Therapeutics Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Addex Therapeutics News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Addex Therapeutics News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.